Log in

Teladoc Health Stock Price, Forecast & Analysis (NYSE:TDOC)

$80.94
+2.05 (+2.60 %)
(As of 11/18/2019 04:49 AM ET)
Today's Range
$78.50
Now: $80.94
$81.48
50-Day Range
$60.84
MA: $71.57
$81.04
52-Week Range
$42.08
Now: $80.94
$82.86
Volume852,537 shs
Average Volume1.28 million shs
Market Capitalization$5.86 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.39
Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone. It serves employers, health plans, health systems, and other entities in approximately 100 countries worldwide. Read More…

Industry, Sector and Symbol

Industry Offices & clinics of medical doctors
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone203-635-2002

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$417.91 million
Book Value$13.73 per share

Profitability

Net Income$-97,080,000.00

Miscellaneous

Employees2,000
Market Cap$5.86 billion
Next Earnings Date2/26/2020 (Estimated)
OptionableOptionable

Receive TDOC News and Ratings via Email

Sign-up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.


Teladoc Health (NYSE:TDOC) Frequently Asked Questions

What is Teladoc Health's stock symbol?

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

How were Teladoc Health's earnings last quarter?

Teladoc Health Inc (NYSE:TDOC) announced its quarterly earnings results on Wednesday, October, 30th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.40) by $0.12. The health services provider earned $137.96 million during the quarter, compared to the consensus estimate of $136.46 million. Teladoc Health had a negative return on equity of 11.23% and a negative net margin of 20.15%. The company's quarterly revenue was up 24.3% on a year-over-year basis. During the same quarter last year, the firm posted ($0.34) EPS. View Teladoc Health's Earnings History.

When is Teladoc Health's next earnings date?

Teladoc Health is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for Teladoc Health.

What price target have analysts set for TDOC?

15 Wall Street analysts have issued 1 year target prices for Teladoc Health's stock. Their forecasts range from $65.00 to $95.00. On average, they anticipate Teladoc Health's share price to reach $79.23 in the next twelve months. This suggests that the stock has a possible downside of 2.1%. View Analyst Price Targets for Teladoc Health.

What is the consensus analysts' recommendation for Teladoc Health?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last year. There are currently 2 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Teladoc Health.

What are Wall Street analysts saying about Teladoc Health stock?

Here are some recent quotes from research analysts about Teladoc Health stock:
  • 1. According to Zacks Investment Research, "Teladoc Health’s first-quarter 2019 loss of 43 cents per share was narrower than the Zacks Consensus Estimate of 44 cents per share, but was wider than the year-ago quarter’s loss of 39 cents per share. The loss can be attributed to higher operating expenses than revenues. Its shares have outperformed the industry in a year’s time. With a number of acquisitions completed since its inception, the company has expanded its distribution capabilities and broadened its service offering. Its international expansion is also impressive. Nevertheless, the company has incurred significant losses and has been unable to generate cash from operations. Its struggle may continue in the coming quarters too. Its high debt level caused a spike in interest expenses, which weighs on operating margins." (5/3/2019)
  • 2. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on TDOC shares. Our price target is $70. After the close on Tuesday, April 30, TDOC reported 1Q18 results that were in line with our estimates and reaffirmed its 2019 guidance. Organic revenue growth was 23% compared with 31% in 4Q18. Importantly, the company indicated that it has expanded its relationship with UnitedHealthcare (UNH – Overweight). The company reiterated that it should be able to maintain organic revenue growth in the 20-30% range next year. The company remains optimistic on Medicare Advantage (MA) plans, but expects more ratable adoption over time. On the surface, TDOC is executing nicely on its virtual health strategy." (4/30/2019)

Has Teladoc Health been receiving favorable news coverage?

News articles about TDOC stock have trended very negative on Monday, according to InfoTrie. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Teladoc Health earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave news articles about the health services provider a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days. View News Stories for Teladoc Health.

Who are some of Teladoc Health's key competitors?

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Shopify (SHOP), Alibaba Group (BABA), Square (SQ), Twilio (TWLO), Netflix (NFLX), Paypal (PYPL), Trade Desk (TTD), salesforce.com (CRM) and Walt Disney (DIS).

Who are Teladoc Health's key executives?

Teladoc Health's management team includes the folowing people:
  • Mr. Jason Nathanial Gorevic, CEO & Director (Age 47)
  • Mr. Peter A. McClennen, Pres & Interim COO (Age 50)
  • Mr. Adam Christian Vandervoort, Chief Legal Officer & Sec. (Age 44)
  • Ms. Stephany Verstraete, Chief Marketing Officer (Age 50)
  • Dr. George Byron Brooks BS EE, M.D., Co-Founder

When did Teladoc Health IPO?

(TDOC) raised $112 million in an initial public offering on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (2.43%), Nikko Asset Management Americas Inc. (1.45%), Sumitomo Mitsui Trust Holdings Inc. (1.45%), Eagle Asset Management Inc. (1.40%), Westwood Management Corp IL (0.85%) and Peregrine Capital Management LLC (0.80%). Company insiders that own Teladoc Health stock include Adam C Vandervoort, Andrew Turitz, Gabriel R Cappucci, Jason N Gorevic, Lewis Levy, Mark Hirschhorn, Michael Goldstein, Michelle Bucaria, Peter A Mcclennen and Stephany Verstraete. View Institutional Ownership Trends for Teladoc Health.

Which institutional investors are selling Teladoc Health stock?

TDOC stock was sold by a variety of institutional investors in the last quarter, including State of New Jersey Common Pension Fund D, Strs Ohio, Emerald Advisers LLC, Emerald Mutual Fund Advisers Trust, Global Thematic Partners LLC, Massachusetts Financial Services Co. MA, Artemis Investment Management LLP and Jaffetilchin Investment Partners LLC. Company insiders that have sold Teladoc Health company stock in the last year include Adam C Vandervoort, Andrew Turitz, Gabriel R Cappucci, Jason N Gorevic, Lewis Levy, Mark Hirschhorn, Michael Goldstein, Michelle Bucaria and Peter A Mcclennen. View Insider Buying and Selling for Teladoc Health.

Which institutional investors are buying Teladoc Health stock?

TDOC stock was acquired by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Nikko Asset Management Americas Inc., Monarch Partners Asset Management LLC, Peregrine Capital Management LLC, Kornitzer Capital Management Inc. KS, First Trust Advisors LP, California Public Employees Retirement System and Envestnet Asset Management Inc.. View Insider Buying and Selling for Teladoc Health.

How do I buy shares of Teladoc Health?

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Teladoc Health's stock price today?

One share of TDOC stock can currently be purchased for approximately $80.94.

How big of a company is Teladoc Health?

Teladoc Health has a market capitalization of $5.86 billion and generates $417.91 million in revenue each year. The health services provider earns $-97,080,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis. Teladoc Health employs 2,000 workers across the globe.View Additional Information About Teladoc Health.

What is Teladoc Health's official website?

The official website for Teladoc Health is http://www.teladoc.com/.

How can I contact Teladoc Health?

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]


MarketBeat Community Rating for Teladoc Health (NYSE TDOC)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  479 (Vote Outperform)
Underperform Votes:  364 (Vote Underperform)
Total Votes:  843
MarketBeat's community ratings are surveys of what our community members think about Teladoc Health and other stocks. Vote "Outperform" if you believe TDOC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TDOC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/18/2019 by MarketBeat.com Staff

Featured Article: Sell-Side Analysts

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel